Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Mar 26:5:19.
doi: 10.1186/1746-1596-5-19.

Expression and prognostic significance of Cox-2 and p-53 in Hodgkin lymphomas: a retrospective study

Affiliations

Expression and prognostic significance of Cox-2 and p-53 in Hodgkin lymphomas: a retrospective study

Nagehan O Barisik et al. Diagn Pathol. .

Abstract

Background: Cyclooxygenase (cox) is the rate-limiting enzyme, which catalyzes the conversion of arachidonic acid into prostaglandins and contributes to the inflammatory process. Cyclooxygenase-2 (cox-2), which is one of the two isoforms, plays a role in tumor progression and carcinogenesis. p53 contributes to apoptosis, DNA renewal and cell cycle. Studies concerning the relationship of cox-2 and p53 expressions and carcinogenesis are available, but the association between cox-2 and p53 in Hodgkin lymphoma (HL) is not exactly known.In our study, we examined the association of cox-2 and p53 expression, with age, stage, histopathological subtype, and survival in HL. We also examined correlation between cox-2 and p53 expression.

Methods: Cox-2 and p53 expressions in Hodgkin-Reed Sternberg cells (HRS) were examined in 54 patients with HL depending on cox-2 expression, stained cases were classified as positive, and unstained cases as negative. Nuclear staining of HRS cells with p53 was evaluated as positive. The classifications of positivity were as follows: negative if<10%; (1+) if 10-25%; (2+) if 25-50%; (3+) if 50-75%, (4+) if >75%.

Results: Cox-2 and p53 expressions were found in 49 (80%) and 29 (46%) patients, respectively. There were differences between histological subtypes according to cox-2 expression (p = 0.012). Mixed cellular (MC) and nodular sclerosing (NS) subtypes were seen most of the patients and cox-2 expression was evaluated mostly in the mixed cellular subtype.There were no statistically significant relationships between p53 and the histopathological subtypes; or between p53, cox-2 and the factors including stage, age and survival; or between p53 and cox-2 expression (p > 0.05).

Conclusion: Considering the significant relationship between the cox-2 expression and the subtypes of HL, cox-2 expression is higher in MC and NS subtypes. However the difference between these two subtypes was not significant. This submission must be advocated by studies with large series.

PubMed Disclaimer

Figures

Figure 1
Figure 1
(cox-2 × 100) cox-2 exspresion in H/R-S cells.
Figure 2
Figure 2
(p53 × 100) p53 expression in H/R-S cells.
Figure 3
Figure 3
Association between Cox-2 expression and survival.

Similar articles

Cited by

References

    1. Ioachim's HL. In: classical Hodgkin lymphoma. 4. Murphy J, McGough J, editor. Philadelphia: Lippincott Williams @ Wilkins; 2009. Medeiros Lymph Node Pathology; pp. 306–324.
    1. Stein H. In: WHO classification of tumours of haematopoietic and lymphoid tissues. Swerdlow SH, Campo E, Haris NL, Jaffe ES, Pileri SA, Stein H, ThieleJ, Vardiman JW, editor. Lyon: IARC Pres; 2008. Hodgkin lymphoma; pp. 321–334.
    1. Chang ET, Zheng T, Weir EG, Borowitz M, Mann RB, Spiegelman D, Mueller NE. Aspirin and the risk of Hodgkin's lymphoma in a population-based case-control study. J Natl Cancer Inst. 2004;96:305–315. - PubMed
    1. Wang J, Taylor CR. Apoptosis and cell cyle-related genes and proteins in classical Hodgkin lymphoma. Appl Immunohistochemistry-Mol Morphology. 2003;11(3):206–213. doi: 10.1097/00129039-200309000-00002. - DOI - PubMed
    1. Rongen MM, Roers A, Küppers R, Rajewsky K, Hansman ML. Mutation of the p53 gene is not a typical feature of Hodgkin and Reed-Sternberg Cells in Hodgkin's disease. Neoplasia. 1999;94(5):1755–1760. - PubMed

Publication types